By Brian Devine ( April 24, 2020, 6:01 PM EDT) -- A group of pharmaceutical and medical device companies have suggested amending the Federal Rules of Civil Procedure to give them a special right to appeal interlocutory orders in multidistrict litigation cases. The proposed rule, as laid out in an April 10 Law360 guest article, would vastly diminish the long-protected right of MDL judges to manage their dockets, and burden the courts of appeal with unnecessary appeals....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.